GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Accuray Inc (FRA:XEJ) » Definitions » Cyclically Adjusted Price-to-FCF

Accuray (FRA:XEJ) Cyclically Adjusted Price-to-FCF : 136.00 (As of Jun. 05, 2025)


View and export this data going back to 2007. Start your Free Trial

What is Accuray Cyclically Adjusted Price-to-FCF?

As of today (2025-06-05), Accuray's current share price is €1.36. Accuray's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 was €0.01. Accuray's Cyclically Adjusted Price-to-FCF for today is 136.00.

The historical rank and industry rank for Accuray's Cyclically Adjusted Price-to-FCF or its related term are showing as below:

FRA:XEJ' s Cyclically Adjusted Price-to-FCF Range Over the Past 10 Years
Min: 136.5   Med: 155   Max: 232.22
Current: 232.22

During the past years, Accuray's highest Cyclically Adjusted Price-to-FCF was 232.22. The lowest was 136.50. And the median was 155.00.

FRA:XEJ's Cyclically Adjusted Price-to-FCF is ranked worse than
94.35% of 248 companies
in the Medical Devices & Instruments industry
Industry Median: 36.435 vs FRA:XEJ: 232.22

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Accuray's adjusted free cash flow per share data for the three months ended in Mar. 2025 was €0.141. Add all the adjusted free cash flow per share for the past 10 years together and divide 10 will get our Cyclically Adjusted FCF per Share, which is €0.01 for the trailing ten years ended in Mar. 2025.

Shiller PE for Stocks: The True Measure of Stock Valuation


Accuray Cyclically Adjusted Price-to-FCF Historical Data

The historical data trend for Accuray's Cyclically Adjusted Price-to-FCF can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Accuray Cyclically Adjusted Price-to-FCF Chart

Accuray Annual Data
Trend Jun15 Jun16 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23 Jun24
Cyclically Adjusted Price-to-FCF
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Accuray Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Cyclically Adjusted Price-to-FCF Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - 263.92

Competitive Comparison of Accuray's Cyclically Adjusted Price-to-FCF

For the Medical Devices subindustry, Accuray's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Accuray's Cyclically Adjusted Price-to-FCF Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Accuray's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Accuray's Cyclically Adjusted Price-to-FCF falls into.


;
;

Accuray Cyclically Adjusted Price-to-FCF Calculation

Like the Shiller PE Ratio, the Cyclically Adjusted Price-to-FCF takes the Free Cash Flow per Share from the past 10 years, adjusts it for inflation, and then calculates the average. This average is then used for the P/FCF calculation. Because it considers this 10-year average, it's often referred to as the CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller to measure the valuation of the overall market. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF.

Accuray's Cyclically Adjusted Price-to-FCF for today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/ Cyclically Adjusted FCF per Share
=1.36/0.01
=136.00

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Accuray's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2025 is calculated as:

For example, Accuray's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2025 was:

Adj_FreeCashFlowPerShare=Free Cash Flow per Share/CPI of Mar. 2025 (Change)*Current CPI (Mar. 2025)
=0.141/134.9266*134.9266
=0.141

Current CPI (Mar. 2025) = 134.9266.

Accuray Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201506 -0.071 100.684 -0.095
201509 0.120 100.392 0.161
201512 0.062 99.792 0.084
201603 -0.120 100.470 -0.161
201606 0.194 101.688 0.257
201609 -0.088 101.861 -0.117
201612 -0.070 101.863 -0.093
201703 -0.146 102.862 -0.192
201706 0.229 103.349 0.299
201709 -0.140 104.136 -0.181
201712 -0.018 104.011 -0.023
201803 0.015 105.290 0.019
201806 0.258 106.317 0.327
201809 -0.192 106.507 -0.243
201812 -0.145 105.998 -0.185
201903 -0.082 107.251 -0.103
201906 0.080 108.070 0.100
201909 -0.265 108.329 -0.330
201912 0.151 108.420 0.188
202003 -0.125 108.902 -0.155
202006 0.175 108.767 0.217
202009 -0.032 109.815 -0.039
202012 0.165 109.897 0.203
202103 0.141 111.754 0.170
202106 0.048 114.631 0.056
202109 -0.094 115.734 -0.110
202112 0.300 117.630 0.344
202203 -0.223 121.301 -0.248
202206 -0.061 125.017 -0.066
202209 -0.013 125.227 -0.014
202212 -0.195 125.222 -0.210
202303 0.218 127.348 0.231
202306 0.008 128.729 0.008
202309 -0.094 129.860 -0.098
202312 -0.059 129.419 -0.062
202403 -0.083 131.776 -0.085
202406 0.088 132.554 0.090
202409 -0.076 133.029 -0.077
202412 0.002 133.157 0.002
202503 0.141 134.927 0.141

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.


Accuray  (FRA:XEJ) Cyclically Adjusted Price-to-FCF Explanation

Compared with the regular Price-to-Free-Cash-Flow, which works poorly for cyclical businesses, the Cyclically Adjusted Price-to-FCF smoothed out the fluctuations of free cash flow during business cycles. Therefore it is more accurate in reflecting the valuation of the company.

If a company has consistent business performance, the Cyclically Adjusted Price-to-FCF should give similar results to regular Price-to-Free-Cash-Flow.


Accuray Cyclically Adjusted Price-to-FCF Related Terms

Thank you for viewing the detailed overview of Accuray's Cyclically Adjusted Price-to-FCF provided by GuruFocus.com. Please click on the following links to see related term pages.


Accuray Business Description

Traded in Other Exchanges
Address
1240 Deming Way, Madison, WI, USA, 53717
Accuray Inc is a radiation oncology company that develops, manufactures, sells and supports precise, innovative treatment solutions which set the standard of radiation therapy care with the aim of helping patients live better lives. The company's technology, The CyberKnife, is used to treat multiple types of cancer and tumors throughout the body. The CyberKnife Systems automatically track, detect and correct for a tumor and patient movement in real-time during the procedure, enabling delivery of precise, high dose radiation with sub-millimetre accuracy while patients breathe normally, without manual user intervention.

Accuray Headlines

No Headlines